No survival benefit for olaparib in BRCA-mutated metastatic pancreatic cancer Presented ByProf. Talia Golan, Sheba Medical Center, Israel TrialPhase 3, POLO ConferenceASCO GI 2021 12 March, 2021 11:02
Maintenance olaparib improved PFS in patients with BRCA+ pancreatic cancer Presented ByDr Hedy L. Kindler, The University of Chicago, USA TrialPhase 3, POLO ConferenceASCO 2019 15 July, 2019 14:07